Product Categories
Country: | United States |
---|---|
Tel: | +1-781-999-5354 |
Mobile: | +1-00000000000 |
E-mail: | marketing@targetmol.com |
QQ: | |
Skype: | Chat Now! |
Address: | 36?Washington?Street, Wellesley?Hills |
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
Product Name | MF | CAS | Details |
---|
Galidesivir triphosphate;BCX6870;Immucillin-A triphosphate;BCX4430-triphosphate | C11H18N5O12P3 | 1467740-78-8 | Details |
G3-C12 | C74H115N23O23S2 | 848301-94-0 | Details |
GABAB receptor antagonist 1 | C18H24O4 | 797-17-1 | Details |
GABAA receptor agent 1 | C13H8ClN3O2 | 1571-87-5 | Details |
Galanthamine N-Oxide | C17H21NO4 | 134332-50-6 | Details |
G6PD activator AG1 | C24H30N4S2 | 421581-52-4 | Details |
Amylase | 9000-92-4 | Details |
gamma-secretase modulator 1 | C24H24N4OS | 1172637-87-4 | Details |
Gallopamil hydrochloride | C28H41ClN2O5 | 16662-46-7 | Details |
Gallopamil | C28H40N2O5 | 16662-47-8 | Details |
Gambogellic acid | C38H44O8 | 173867-04-4 | Details |
Gamitrinib TPP | C52H65N3O8P+ | 1131626-46-4 | Details |
Gamitrinib TPP hexafluorophosphate | C52H65F6N3O8P2 | 1131626-47-5 | Details |
Gamma-glutamylcysteine TFA;Gamma-glutamylcysteine (TFA);γ-glutamylcysteine (TFA) | C20H32N6O12S2 | 283159-88-6 | Details |
gamma-secretase modulator 2 | C25H22F4N6O2 | 1093978-89-2 | Details |
gamma-secretase modulator 3 | C24H23FN4OS | 1431697-84-5 | Details |
γ-Secretase modulator 4 | C23H19FN4O2 | 1420200-82-3 | Details |
Lerociclib | C26H34N8O | 1628256-23-4 | Details |
Lerociclib dihydrochloride | C26H35ClN8O | 2097938-59-3 | Details |
gamma-Secretase Modulators;Amyloid-β production inhibitor;γ-Secretase Modulators | C26H24F3N3O3 | 937812-80-1 | Details |
G907 | C26H24ClNO3 | 2244035-16-1 | Details |
GCN2iB | C18H12ClF2N5O3S | 2183470-12-2 | Details |
GCN2-IN-6 | C19H12Cl2F2N4O3S | 2183470-09-7 | Details |
GCN2-IN-1 | C19H18N10O | 1448693-69-3 | Details |
GC7 Sulfate | C8H22N4O4S | 150417-90-6 | Details |
Clorsulon | C8H8Cl3N3O4S2 | 60200-06-8 | Details |
Garcinol | C38H50O6 | 78824-30-3 | Details |
Gastrofensin AN 5 free base | C19H21ClN2O2 | 89845-16-9 | Details |
Salbutamol;AH-3365;Albuterol | C13H21NO3 | 18559-94-9 | Details |
Genz-123346 | C52H82N4O14 | 943344-58-9 | Details |
Gemfibrozil 1-O-β-glucuronide | C21H30O9 | 91683-38-4 | Details |
GFB-8438 | C16H14ClF3N4O2 | 2304549-73-1 | Details |
GGTI-2418 | C23H31N5O4 | 501010-06-6 | Details |
Ginsenoside Ra3 | C59H100O27 | 90985-77-6 | Details |
GENZ-882706;RA03546849 | C26H25N5O3 | 2070864-35-4 | Details |
Gepotidacin;GSK2140944 | C24H28N6O3 | 1075236-89-3 | Details |
Germacrene D | C15H24 | 23986-74-5 | Details |
GF 15 | C23H21ClO6 | 888042-13-5 | Details |
GGTI298 | C27H33N3O3S | 180977-44-0 | Details |
Giredestrant;GDC-9545 | C27H31F5N4O | 1953133-47-5 | Details |
Doxycycline hydrochloride;Hyclate;Vibramycin;Doxylin | C22H25ClN2O8 | 10592-13-9 | Details |
Glutaminyl Cyclase Inhibitor 3 | C24H32N6O2S | 2092921-50-9 | Details |
Glucagon receptor antagonists-5 | C30H29ClF3N3O3 | 2200274-63-9 | Details |
Glucagon receptor antagonists-3 | C22H30FNO2 | 202917-17-7 | Details |
Glucagon receptor antagonists-2 | C22H30FNO2 | 202917-18-8 | Details |
Glucagon receptor antagonists-1 | C29H34FNO2 | 503559-84-0 | Details |
Glucocorticoid receptor agonist | C20H20F4N2O2 | 1245526-82-2 | Details |
Glucokinase activator 1 | C27H20F2N2O7S2 | 1328987-85-4 | Details |
Gisadenafil besylate;UK 369003-26 | C29H39N7O8S2 | 334827-98-4 | Details |
GKA50 | C26H28N2O6 | 851884-87-2 | Details |
Gln-AMS | C15H22N8O8S | 209543-57-7 | Details |
GLP-1 receptor agonist 3 | C31H30FN5O4 | 2230200-09-4 | Details |
GLP-1 receptor agonist 4 | C51H44Cl2N4O6 | 1187061-62-6 | Details |
TT-OAD2 free base | C50H47Cl2N3O6 | 1246826-07-2 | Details |
GLP-1 receptor agonist 2 | C30H31ClFN5O4 | 2230197-64-3 | Details |
GLP-1 receptor agonist 1 | C48H48F2N10O5 | 2212020-52-3 | Details |
GET73 | C13H16F3NO2 | 202402-01-5 | Details |
Gemilukast | C36H37F2NO5 | 1232861-58-3 | Details |
Gemcabene | C16H30O5 | 183293-82-5 | Details |
Glycolic acid oxidase inhibitor 1 | C16H10BrNO3 | 77529-42-1 | Details |
Gly-β-MCA | C26H43NO6 | 66225-78-3 | Details |
GLPG0492 (R enantiomer);GLPG0492 R enantiomer | C19H14F3N3O3 | 1215085-93-0 | Details |
GLP-26 | C19H17F2N3O3 | 2133017-36-2 | Details |
GLPG0492 | C19H14F3N3O3 | 1215085-92-9 | Details |
GLPG1205 | C22H22N2O4 | 1445847-37-9 | Details |
Fenbendazole | C15H13N3O2S | 43210-67-9 | Details |
O6BTG-octylglucoside;Glucose-conjugated MGMT inhibitor | C24H34BrN5O7S | 382607-78-5 | Details |
GLUT4 activator 1 | C23H21FN4O3S | 2253733-37-6 | Details |
Glutaminase-IN-1;CB839 derivative | C26H24F3N7O3Se | 2247127-79-1 | Details |
IPN60090 | C24H27F3N8O3 | 1853164-83-6 | Details |
Clindamycin phosphate | C18H34ClN2O8PS | 24729-96-2 | Details |
GDC-0834 | C33H36N6O3S | 1133432-49-1 | Details |
GDC-0834 Racemate | C33H36N6O3S | 1133432-46-8 | Details |
Gefitinib-d8;ZD1839 D8;Gefitinib D8 | C22H24ClFN4O3 | 857091-32-8 | Details |
Gefitinib N-oxide | C22H24ClFN4O4 | 847949-51-3 | Details |
Gemcabene calcium;PD-72953 calcium | C16H32CaO5 | 209789-08-2 | Details |
Pictilisib dimethanesulfonate | C24H30N7O6S3 | 957054-33-0 | Details |
GDP-?α-D-?mannose disodium | C16H23N5Na2O16P2 | 148296-46-2 | Details |
GDP366 | C20H17N5OS | 501698-03-9 | Details |
GDC-0927;SRN-927 | C28H28FNO4 | 1642297-01-5 | Details |
Taurocholic acid sodium salt hydrate;Taurocholic Acid sodium hydrate;Sodium taurocholate hydrate | C26H46NNaO8S | 345909-26-4 | Details |
Ganodermanontriol | C30H48O4 | 106518-63-2 | Details |
GBR 12783 | C28H32N2O | 67469-57-2 | Details |
GB-88 | C32H42N4O4 | 1416435-96-5 | Details |
GB-110 | C33H48N6O5 | 1252806-70-4 | Details |
GDC-0834 S-enantiomer | C33H36N6O3S | 1133432-50-4 | Details |
GDC-0276 | C24H31FN2O4S | 1494581-70-2 | Details |
GC 14 | C26H27NO6 | 447415-34-1 | Details |
Ganoderic acid F | C32H42O9 | 98665-15-7 | Details |
Ganoderic acid TR | C30H44O4 | 862893-75-2 | Details |
GATA4-NKX2-5-IN-1 | C21H23N3O2 | 544681-96-1 | Details |
Glyco-Obeticholic acid | C28H47NO5 | 863239-60-5 | Details |
Antibacterial compound 2 | C22H30FN5O6 | 170104-58-2 | Details |
Glutaminyl Cyclase Inhibitor 2 | C19H20FN3 | 1884546-29-5 | Details |
Glutaminyl Cyclase Inhibitor 1 | C21H24FN3O2 | 2110449-60-8 | Details |
Glutaminyl Cyclase Inhibitor 4 | C22H33N5O3 | 2376329-36-9 | Details |
Carbenicillin disodium | C17H19N2NaO6S | 4800-94-6 | Details |
Glyoxalase I inhibitor free base | C21H29BrN4O8S | 174568-92-4 | Details |
Glycosidase-IN-2 | C13H23NO5 | 476310-39-1 | Details |
Glycosidase-IN-1 | C13H23NO5 | 170376-12-2 | Details |
Product Total: Product Page: | ||||
5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 |